Daijiworld Media Network- London

London, Apr 8: Health authorities in the United Kingdom have confirmed a fresh case of mpox (formerly known as monkeypox) involving the Clade Ib variant, marking the fourth such infection reported since the beginning of this year.

The patient, located in northeast England, was diagnosed in March. What has raised concern among officials is the fact that the individual had no travel history and no known links to previously confirmed mpox cases. This has prompted the UK Health Security Agency (UKHSA) to launch a thorough investigation into the source of the infection, with a focus on identifying any undetected community transmission.

According to a statement issued by UKHSA, close contacts of the patient have been traced and are under observation. So far, no further cases have emerged, and officials have reassured the public that the overall risk remains low.

Clade Ib is considered a more severe strain of mpox and has been associated with the global health alert issued by the World Health Organization (WHO). It is genetically distinct from Clade II, the strain responsible for the global outbreak in 2022. Despite its severity, the UKHSA had earlier clarified that both Clade Ia and Clade Ib variants are no longer classified as high consequence infectious diseases in the country.

Medical experts have emphasized the need for public awareness and timely reporting of symptoms, especially in light of the unexplained nature of the recent case. Authorities are urging healthcare providers to remain vigilant and continue routine surveillance.

As investigations continue, the UKHSA has reiterated its commitment to transparency and public safety, ensuring that all necessary precautions are in place to contain any potential spread.